Meta-iodobenzyl guanidine for detection and staging of neuroendocrine tumors

An important application of MIBG imaging is to demonstrate targeting of therapeutic I-131 MIBG. Imaging is thus useful in the detection of disease as well as in the demonstration of adequate targeting for therapy - either qualitatively or quantitatively with dosimetry. The latter will probably be feasible with PET using isotopes like iodine-124, and perhaps with single photon emission computed tomography/computed tomography. Imaging with MIBG will continue to be the mainstay for detection and staging of GEP-NET. More importantly, perhaps, imaging with MIBG will form part of an imaging continuum, including assessment of glycolytic rate and somatostatin receptor status, that will enable assessment of tumor phenotype and guide management.